(Q38682548)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2671533%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

review article

1 reference

title

Subacute cutaneous lupus erythematosus: a decade's perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2671533%20AND%20SRC:MED&resulttype=core&format=json

subacute cutaneous lupus erythematosus

3 October 2019

main subject

0 references

author name string

R D Sontheimer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2671533%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

publication date

1 September 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2671533%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

3 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2671533%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2671533%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2671533%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

page(s)

1073-1090

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2671533%20AND%20SRC:MED&resulttype=core&format=json

Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens

3 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Lupus erythematosus and toxic epidermal necrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Lupus erythematosus gyratus repens. Report of a case associated with a lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of forty-nine patients seen in a nonreferral setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus and porphyria cutanea tarda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Clofazimine in the treatment of annular lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus presenting as erythroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

A distinctive eruption in patients receiving oxprenolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Distinctive cutaneous subsets in the spectrum of lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

The anti-Ro antibody system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Annular subacute cutaneous lupus erythematosus responsive to dapsone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus in Iceland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Thalidomide treatment of subacute cutaneous lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Dust-like particles: a specific direct immunofluorescence pattern in sub-acute cutaneous lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

C4 null phenotypes among lupus erythematosus patients are predominantly the result of deletions covering C4 and closely linked 21-hydroxylase A genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Sub-acute cutaneous lupus erythematosus and gluten sensitive enteropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Efficiency of acitretin in the treatment of cutaneous lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus associated with breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute cutaneous lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Clinical significance of subacute cutaneous lupus erythematosus skin lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Questions pertaining to the true frequencies with which anti-Ro/SS-A autoantibody and the HLA-DR3 phenotype occur in subacute cutaneous lupus erythematosus patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Subacute Cutaneous Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Systemic lupus erythematosus with anti-Ro antibodies: clinical, histologic and immunologic findings. Report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Severe visceral disease in subacute cutaneous lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

Lupus and non-lupus cutaneous manifestations in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930620-4

10.1016/S0025-7125(16)30620-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2671533%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

1 reference